HOUSTON, Jan. 28, 2005 (PRIMEZONE) -- Judith Segall, Vice President of Operations for BioTime, Inc. (AMEX:BTX), will appear Sunday night, January 30th at 9:10 pm ET on "Corporate Strategies with Tim Connolly". Ms. Segall will discuss the Company's medical advances, domestic and international markets, pipeline of products, and their financial standing.
Recent guests have included Enterprise Products (NYSE:EPD) CEO Dan Duncan, Celgene's CEO John Jackson, Landry's CEO Tilman Fertitta, John Murphy, Mario Gabelli, former SEC Chairman Arthur Levitt, former Compaq CEO Eckard Pfeiffer, Money Manager Louis Navellier, and many others. Listeners may call in questions live and toll free to Tobin and Tim Connolly at 1-866-606-TALK (8255). The Business Talk Radio Show may be heard on KSEV AM 700 in Houston, on over 375 affiliate stations nationwide listed at CRN1 www.cableradionetwork.com, or on the Internet at www.businesstalkradio.net. This hour of "Corporate Strategies with Tim Connolly" is hosted by Tim Connolly of Corporate Strategies Merchant Bankers (www.corporate-strategies.net). Noted Economist Mike King of Princeton Research provides live technical analysis for the show.
About BioTime, Inc. - BioTime has developed aqueous synthetic solutions for use in a variety of medical applications. The Company's Hextend(R) plasma volume expander maintains circulatory system fluid volume and oncotic pressure during surgery. Hextend(R) is marketed in the United States and Canada by Hospira, Inc. CJ Corporation also has an exclusive license to manufacture and sell Hextend(R) and other of our plasma volume expanders, PentaLyte(R), in South Korea. Products under development at BioTime include other plasma volume expanders, and a blood replacement solution for organ and tissue preservation at very low temperatures. Judith Segall is Vice President-Operations, Office of the President and one of the founding executive officers and directors of BioTime along with her late husband and former CEO, Dr. Paul Segall. Ms. Segall worked closely with her husband in the management of BioTime's business from the inception of the company in 1990, including its product development and licensing programs. Along with other BioTime founders, she is the co-author of numerous journal articles, abstracts, and patents in the area of plasma volume expansion, blood substitution and low temperature medicine. Ms. Segall received a B.S. in Nutrition and Clinical Dietetics from the University of California at Berkeley in 1989.
About Corporate Strategies, Inc. - Corporate Strategies, Inc. (www.corporate-strategies.net) is a Merchant Bank in the traditional European sense of the word. As the term has evolved from the 18th Century to today, Merchant Banking describes an enterprise that not only finances a company's product or service, but also assists in developing a comprehensive business strategy. Corporate Strategies is comprised of seasoned executives with extensive experience in merchant banking, including business development and strategy, public and private company corporate finance, capital markets research, human resources, due diligence and transaction negotiation and execution.
"Corporate Strategies with Tim Connolly" is live talk radio.with the Titans of Business who move financial markets! The show is hosted by Tim Connolly, CEO of Merchant Banker Corporate Strategies, Inc. The Executive Producer of the show is broadcast news veteran Jan Carson, an award winning journalist with more than 20 years experience as a top rated television news anchor and reporter for NBC, ABC and CBS network affiliates. "Corporate Strategies with Tim Connolly" features financial experts from across the nation providing the latest intelligence on equities, income investments, and a variety of risk, equity and option strategies. Recent guests have included Landry's CEO Tilman Fertitta, Matt Simmons, John Olson, Mario Gabelli, former SEC Chairman Arthur Levitt, former Compaq CEO Eckard Pfeiffer, Money Manager Louis Navellier, and many others.